Unilateral Vocal Fold Immobility in Children

M Elise Graham1, Marshall E Smith2

  • 1Department of Otolaryngology-Head and Neck Surgery, Children's Hospital at London Health Sciences Centre, Schulich School of Medicine, Western University, 800 Commissioner's Road East, London, Ontario N6A 5W9, Canada.

Insights

Unilateral vocal fold paralysis (UVFP) in children, often caused by iatrogenic injury, impacts voice, swallowing, and breathing. Laryngeal reinnervation offers a promising solution for functional improvement.

Area of Science:

  • Otolaryngology
  • Pediatric Medicine
  • Speech-Language Pathology

Background:

  • Unilateral vocal fold paralysis (UVFP) in children significantly affects laryngeal function, impacting voice, swallowing, and breathing.
  • Iatrogenic injury is the most common cause of UVFP in pediatric patients.
  • Diagnosis requires a thorough history, physical examination including flexible nasopharyngoscopy, and potentially imaging.

Purpose of the Study:

  • To outline the diagnostic approach for pediatric UVFP.
  • To discuss current management strategies for UVFP in children.
  • To highlight the role of laryngeal reinnervation in improving vocal fold function.

Main Methods:

  • Review of clinical presentation and diagnostic workup for pediatric UVFP.
  • Analysis of management options, including conservative and surgical interventions.
  • Evaluation of laryngeal reinnervation as a therapeutic modality.

Main Results:

  • UVFP in children necessitates a comprehensive evaluation to identify the cause and extent of dysfunction.
  • Management strategies focus on improving voice quality, reducing aspiration risk, and enhancing the child's quality of life.
  • Laryngeal reinnervation techniques are emerging as effective options for restoring vocal fold bulk and tone.

Conclusions:

  • Early and accurate diagnosis of pediatric UVFP is crucial for effective management.
  • A multidisciplinary approach is often required to address the complex needs of children with UVFP.
  • Laryngeal reinnervation holds significant potential for long-term functional recovery in pediatric UVFP.

Related Concept Videos

Protein Folding01:22

Protein Folding

Overview
127.0K
Protein Folding01:25

Protein Folding

Proteins are chains of amino acids linked together by peptide bonds. Upon synthesis, a protein folds into a three-dimensional conformation, critical to its biological function. Interactions between its constituent amino acids guide protein folding, and hence the protein structure is primarily dependent on its amino acid sequence.
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
11.3K
Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
19.7K
Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

14.9K
Protein Folding Quality Check in the RER01:29

Protein Folding Quality Check in the RER

ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
5.1K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
266